| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |